222 related articles for article (PubMed ID: 19996921)
1. Restorative and rejection-associated lymphangiogenesis after renal transplantation: friend or foe?
Vass DG; Hughes J; Marson LP
Transplantation; 2009 Dec; 88(11):1237-9. PubMed ID: 19996921
[TBL] [Abstract][Full Text] [Related]
2. Targeted inhibition of renal Rho kinase reduces macrophage infiltration and lymphangiogenesis in acute renal allograft rejection.
Poosti F; Yazdani S; Dolman ME; Kok RJ; Chen C; Ding G; Lacombe M; Prakash J; van den Born J; Hillebrands JL; van Goor H; de Borst MH
Eur J Pharmacol; 2012 Nov; 694(1-3):111-9. PubMed ID: 22964464
[TBL] [Abstract][Full Text] [Related]
3. Lymphatic endothelial progenitor cells contribute to de novo lymphangiogenesis in human renal transplants.
Kerjaschki D; Huttary N; Raab I; Regele H; Bojarski-Nagy K; Bartel G; Kröber SM; Greinix H; Rosenmaier A; Karlhofer F; Wick N; Mazal PR
Nat Med; 2006 Feb; 12(2):230-4. PubMed ID: 16415878
[TBL] [Abstract][Full Text] [Related]
4. Lymphatic neoangiogenesis in renal transplants: a driving force of chronic rejection?
Kerjaschki D
J Nephrol; 2006; 19(4):403-6. PubMed ID: 17048196
[TBL] [Abstract][Full Text] [Related]
5. Lymphangiogenesis in a mouse model of renal transplant rejection extends life span of the recipients.
Pedersen MS; Müller M; Rülicke T; Leitner N; Kain R; Regele H; Wang S; Gröne HJ; Rong S; Haller H; Gueler F; Rees AJ; Kerjaschki D
Kidney Int; 2020 Jan; 97(1):89-94. PubMed ID: 31718844
[TBL] [Abstract][Full Text] [Related]
6. [Functional loss of the transplanted kidney: immunological and non-immunological factors].
Cattaneo D; Perico N; Remuzzi G
G Ital Nefrol; 2004; 21 Suppl 26():S28-33. PubMed ID: 15732041
[TBL] [Abstract][Full Text] [Related]
7. Lymphangiogenesis is upregulated in kidneys of patients with multiple myeloma.
Zimmer JK; Dahdal S; Mühlfeld C; Bergmann IP; Gugger M; Huynh-Do U
Anat Rec (Hoboken); 2010 Sep; 293(9):1497-505. PubMed ID: 20648479
[TBL] [Abstract][Full Text] [Related]
8. Chronic renal allograft dysfunction: risk factors, immunology and prevention.
Fadili W; Habib Allah M; Laouad I
Arab J Nephrol Transplant; 2013 Jan; 6(1):45-50. PubMed ID: 23282234
[TBL] [Abstract][Full Text] [Related]
9. The exciting "bench to bedside" journey of cell therapies for acute kidney injury and renal transplantation.
Dellepiane S; Medica D; Quercia AD; Cantaluppi V
J Nephrol; 2017 Jun; 30(3):319-336. PubMed ID: 28321822
[TBL] [Abstract][Full Text] [Related]
10. Differential expression of proteoglycans in tissue remodeling and lymphangiogenesis after experimental renal transplantation in rats.
Rienstra H; Katta K; Celie JW; van Goor H; Navis G; van den Born J; Hillebrands JL
PLoS One; 2010 Feb; 5(2):e9095. PubMed ID: 20140097
[TBL] [Abstract][Full Text] [Related]
11. Chronic allograft nephropathy: what have we learned from protocol biopsies?
Bosmans JL; Ysebaert DK; Verpooten GA
Transplantation; 2008 Apr; 85(7 Suppl):S38-41. PubMed ID: 18401262
[TBL] [Abstract][Full Text] [Related]
12. Tubular engraftment and myofibroblast differentiation of recipient-derived cells after experimental kidney transplantation.
Broekema M; Harmsen MC; Koerts JA; van Kooten TG; Navis G; van Luyn MJ; Popa ER
Transplantation; 2007 Oct; 84(8):1003-11. PubMed ID: 17989606
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of serum tumor necrosis factor alpha and its correlation with histology in chronic kidney disease, stable renal transplant and rejection cases.
Sonkar GK; ; Singh RG
Saudi J Kidney Dis Transpl; 2009 Nov; 20(6):1000-4. PubMed ID: 19861860
[TBL] [Abstract][Full Text] [Related]
14. [Lymphoid neogenesis and lymphangiogenesis: two newcomers in the pathophysiology of chronic rejection].
Attuil-Audenis V; Duthey A; Patey N; Gautreau C; McGregor B; Morelon E; Michel JB; Nicoletti A; Thaunat O
Nephrol Ther; 2009 Apr; 5(2):91-6. PubMed ID: 18678539
[TBL] [Abstract][Full Text] [Related]
15. Corneal lymphangiogenesis: implications in immunity.
Patel SP; Dana R
Semin Ophthalmol; 2009; 24(3):135-8. PubMed ID: 19437348
[TBL] [Abstract][Full Text] [Related]
16. Pathology of chronic humoral rejection.
Colvin RB
Contrib Nephrol; 2009; 162():75-86. PubMed ID: 19001815
[TBL] [Abstract][Full Text] [Related]
17. Value of serum cystatin C as a marker of renal function in the early post kidney transplant period.
Geramizadeh B; Azarpira N; Ayatollahi M; Rais-Jalali GA; Aghdai M; Yaghoobi R; Banihashemi M; Malekpour Z; Malek-Hosseini SA
Saudi J Kidney Dis Transpl; 2009 Nov; 20(6):1015-7. PubMed ID: 19861863
[TBL] [Abstract][Full Text] [Related]
18. The potential role of perivascular lymphatic vessels in preservation of kidney allograft function.
Tsuchimoto A; Nakano T; Hasegawa S; Masutani K; Matsukuma Y; Eriguchi M; Nagata M; Nishiki T; Kitada H; Tanaka M; Kitazono T; Tsuruya K
Clin Exp Nephrol; 2017 Aug; 21(4):721-731. PubMed ID: 27770292
[TBL] [Abstract][Full Text] [Related]
19. Lymphoid neogenesis in chronic rejection.
Thaunat O; Nicoletti A
Curr Opin Organ Transplant; 2008 Feb; 13(1):16-9. PubMed ID: 18660701
[TBL] [Abstract][Full Text] [Related]
20. Detailed examination of HLA antibody development on renal allograft failure and function.
Zhu L; Lee PC; Everly MJ; Terasaki PI
Clin Transpl; 2008; ():171-87. PubMed ID: 19711514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
